USFDA16 May 2024, 09:32 pm
USFDA Completes Inspection at Indoco Remedies API Kilo Lab and IAS Division with Zero Observations
AI Summary
Indoco Remedies Ltd. announced that the USFDA successfully completed inspections of their API Kilo Lab manufacturing facility and Indoco Analytical Solutions division with no Form 483 observations. This achievement highlights the company's commitment to maintaining high standards of quality and compliance.
Key Highlights
- USFDA completed inspections of Indoco Remedies API Kilo Lab and IAS division
- No Form 483 observations were issued
- Indoco reaffirms commitment to quality and compliance